Vasculitis - Can we use rituximab to prevent the return of ANCA vasculitis?
Learn more about our research aiming to show that rituximab is better than standard treatments at stopping ANCA vasculitis returning over a four-year period.
Live research projects
Vasculitis - Improving healthcare delivery for patients with rare rheumatic diseases
Learn more about our Health Services Research grant for the improvement of healthcare delivery to patients with rare rheumatic diseases (e.g. vasculitis).
Vasculitis - Improving healthcare delivery for patients with rare rheumatic diseases
Learn about our research into which areas of healthcare delivery are associated with important health outcomes for vasculitis patients (to improve services).
Vasculitis - Investigating the impact of the bacteria found in the nose on granulomatosis with polyangiitis
Learn more about investigating the impact of the bacteria found in the nose on granulomatosis with polyangiitis.
Vasculitis - Investigating the potential of gene therapy for treatment of DADA2 vasculitis
Learn about our research which aims to investigate the potential use of gene therapy to treat a specific type of vasculitis, known as DADA2 vasculitis.
Vasculitis - Vaccine responses in ANCA associated vasculitis (AAV)
Learn about our research into whether rituximab is negatively affecting vaccines and if a combination of vaccines is better at reducing the risk of infection.